Anika Therapeutics, Inc. (ANIK) Reports Improved Q4 EPS of $0.21
Get Alerts ANIK Hot Sheet
Price: $25.90 +0.43%
Revenue Growth %: +9.6%
Financial Fact:
Total operating expenses: 12.1M
Today's EPS Names:
NLY, CP, RUSHA, More
Revenue Growth %: +9.6%
Financial Fact:
Total operating expenses: 12.1M
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q4 EPS of $0.21, versus $0.10 reported last year. Revenue for the quarter came in at $18.4 million, versus $14.7 million reported last year.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meritage Homes Corporation (MTH) Tops Q1 EPS by 151c; offers guidance
- O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
- First Bancshares (FBMS) Tops Q1 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!